Page 569«..1020..568569570571..580590..»

‘It is the closest thing to magic.’ Trauma techniques that can help people through hard times – East Idaho News

Posted: Published on October 17th, 2020

stock photo IDAHO FALLS Whether its the death of a loved one, a bad accident or injury, or even abuse or assault there is a decent chance that a person will experience trauma during their lifetime. People experience trauma for a variety of different reasons, and the experience is a little different for everyone. Continue reading →

Posted in Brain Injury Treatment | Comments Off on ‘It is the closest thing to magic.’ Trauma techniques that can help people through hard times – East Idaho News

Mild Traumatic Brain Injury Treatment Market: Dynamics, Segment, Application and Supply Demand Analysis 2020-2030 – PRnews Leader

Posted: Published on October 17th, 2020

Prophecy Market Insights offers the latest published report on Mild Traumatic Brain Injury Treatment market analysis and forecast 2019-2029. Continue reading →

Posted in Brain Injury Treatment | Comments Off on Mild Traumatic Brain Injury Treatment Market: Dynamics, Segment, Application and Supply Demand Analysis 2020-2030 – PRnews Leader

Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV…

Posted: Published on October 17th, 2020

Details Category: More News Published on Saturday, 17 October 2020 16:52 Hits: 101 SOUTH SAN FRANCISCO, CA, USA I October 15, 2020 I Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, will host a virtual R&D Day webinar today highlighting progress across the Companys broad and diverse biotherapeutics portfolio enabled by its BBB transport vehicle (TV) platform Continue reading →

Posted in Brain Injury Treatment | Comments Off on Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV…

Devastated dad’s heartache as ‘kind and loving’ Stoke City fan son, 38, killed in high-speed head-on crash – Stoke-on-Trent Live

Posted: Published on October 17th, 2020

The devastated father of a man killed in a road collision has paid tribute to his 'kind, loving and outgoing' son. Stephen Bevans, aged 38, died after his white Peugeot van crashed head-on with a Land Rover Discovery on the A53 at Ashley on the evening of August 7 last year. An inquest into his death at Stoke-on-Trent Civic Centre heard his mental health had deteriorated and he had been drinking and using cocaine when he decided to overtake several vehicles Continue reading →

Posted in Brain Injury Treatment | Comments Off on Devastated dad’s heartache as ‘kind and loving’ Stoke City fan son, 38, killed in high-speed head-on crash – Stoke-on-Trent Live

Around the Region – October 18th | | journal-news.net – Martinsburg Journal

Posted: Published on October 17th, 2020

WVU Medicine clinic moving to new office MARTINSBURG - The WVU Medicine Children's Pediatric Subspecialty and Telemedicine Clinic in Martinsburg will relocate to a new office effective Monday. The clinic brings the expertise of WVU Medicine Children's pediatric subspecialists to families in the Eastern Panhandle. Using state-of-the-art telemedicine technology, patients in Martinsburg are able to interact in real-time with pediatric subspecialists in Morgantown Continue reading →

Posted in Pediatric Cardiology | Comments Off on Around the Region – October 18th | | journal-news.net – Martinsburg Journal

Seattle Gummy Company Secures The First (IND) Gummy Drug Approval From FDA – BioSpace

Posted: Published on October 17th, 2020

SEATTLE, Oct. 15, 2020 /PRNewswire/ --Seattle Gummy Company's breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company's allergy gummy medication, designated as IND 140312. Led by founder and CEO, Dr. Continue reading →

Posted in Pediatric Cardiology | Comments Off on Seattle Gummy Company Secures The First (IND) Gummy Drug Approval From FDA – BioSpace

Women Who Experience a Myocardial Infarction at a Young Age Have Worse Outcomes Compared with Men: the Mass General Brigham YOUNG-MI Registry -…

Posted: Published on October 17th, 2020

Aims:There are sex differences in presentation, treatment, and outcomes of myocardial infarction (MI) but less is known about these differences in a younger patient population. The objective of this study was to investigate sex differences among individuals who experience their first MI at a young age. Continue reading →

Posted in Myocardial Infarction | Comments Off on Women Who Experience a Myocardial Infarction at a Young Age Have Worse Outcomes Compared with Men: the Mass General Brigham YOUNG-MI Registry -…

Canakinumab Found to Reduce Total Number of CV Events in Patients With Prior Myocardial Infarction – The Cardiology Advisor

Posted: Published on October 17th, 2020

Anti-inflammatory therapy with canakinumab was found to reduce the total number of cardiovascular events in patients with prior myocardial infarction and evidence of residual inflammatory risk, according to a published study in the Journal of the American College of Cardiology. A total of 10,061 patients with a prior history of myocardial infarction and a high-sensitivity C-reactive protein (hsCRP) levels 2 mg/L were enrolled in the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS; ClinicalTrials.gov Identifier: NCT01327846). Participants were randomly assigned to received placebo or the interleukin (IL)-1 inhibitor canakinumab at 50 mg, 150 mg, or 300 mg once every 3 months Continue reading →

Posted in Myocardial Infarction | Comments Off on Canakinumab Found to Reduce Total Number of CV Events in Patients With Prior Myocardial Infarction – The Cardiology Advisor

Vanderbilt University Medical Center’s Acute Myocardial Infarction, Discharged Alive MSPB average increased by almost 13% – Dexur

Posted: Published on October 17th, 2020

Vanderbilt University Medical Centers Acute Myocardial Infarction, Discharged Alive MSPB average increased by almost 13% Want a Demo of Dexur's full capabilities? By: Parvathy Rajagopal &nbspOct. 16, 2020 Dexur analyzed Medicare Claims data and replicated CMS algorithms to calculate Medicare Spending per Beneficiary (MSPB) cost per episode of Vanderbilt University Medical Center and found that the cost per episode was $33,526 for Acute Myocardial Infarction, Discharged Alive, from Jan-Dec 2019. Continue reading →

Posted in Myocardial Infarction | Comments Off on Vanderbilt University Medical Center’s Acute Myocardial Infarction, Discharged Alive MSPB average increased by almost 13% – Dexur

TCT: Meta-Analysis of Bivalirudin vs. Heparin in Patients with MI Examines Mortality and Bleeding Rates – Cath Lab Digest

Posted: Published on October 17th, 2020

Results of an Individual Patient Data Pooled Analysis Reported at TCT Connect NEW YORK October 15, 2020 An individual patient data pooled analysis comparing the use of bivalirudin versus heparin in heart attack patients undergoing percutaneous coronary intervention (PCI) found that bivalirudin use was associated with similar overall rates of 30-day mortality across all heart attack patients, but lower rates of serious bleeding events. Moreover, mortality was reduced in patients with ST-segment elevation myocardial infarction (STEMI) who were treated with a post-PCI bivalirudin infusion. Findings were reported today at TCT Connect, the 32ndannual scientific symposium of the Cardiovascular Research Foundation (CRF). Continue reading →

Posted in Myocardial Infarction | Comments Off on TCT: Meta-Analysis of Bivalirudin vs. Heparin in Patients with MI Examines Mortality and Bleeding Rates – Cath Lab Digest

Page 569«..1020..568569570571..580590..»